Prioritisation: Focussing our reviews on the questions and outcomes that matter to our stakeholders.

Current high priority reviews eligible for an update:

• Continuous glucose monitoring systems for diabetes mellitus
• Glucagon-like peptide analogues for type 2 diabetes mellitus
• Exercise for overweight or obese adults

Please note that this list is not definitive and will be subject to periodic revision as priorities change.